Quantcast

Latest epilepsy Stories

2014-02-25 08:31:10

LOS ANGELES, Feb. 25, 2014 /PRNewswire/ -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch(TM) eTNS(TM) System for the treatment of neurological and neuropsychiatric disorders, announced the appointment of David Hayes, Esq. as Senior Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary. Prior to joining NeuroSigma, Mr. Hayes was a partner at Hayes and Boone, LLP, since...

2014-02-24 16:25:23

Photo Op of Local Leaders CHICAGO, Feb. 24, 2014 /PRNewswire-USNewswire/ -- The common bond of the love of a child with epilepsy will bring three of the most influential leaders in Chicago together for the kick-off fundraising event towards the goal of $1.5 million for research for a cure for epilepsy. Chicago Bears General Manager Phil Emery and Ventas Chairman & CEO Debra A. Cafaro will join Susan Axelrod, founding chair of Citizens United for Research in Epilepsy (CURE), at...

2014-02-21 11:36:15

Two new smart phone applications may help people detect epileptic seizures and get better stroke treatment, according to two studies released today that will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014. In the first study, an epilepsy app was designed to help non-doctors determine if a person is having an epileptic seizure. "It can often be difficult to determine whether someone is having an epileptic seizure," said...

2014-02-20 08:29:34

Proprietary Technology Provides Automatic Stimulation upon Seizure Detection HOUSTON, Feb. 20, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) announced today the CE Mark (Conformité Européenne) approval in Europe for the AspireSR generator, the novel sixth-generation VNS Therapy generator. The AspireSR generator provides the well-established benefits of VNS Therapy, coupled with a new feature - Automatic Stimulation in response to detection of a seizure. Proprietary...

2014-02-19 16:24:40

HOUSTON, Feb. 19, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences. Greg Browne, Cyberonics' Chief Financial Officer, will participate in one-on-one meetings with investors during the RBC Capital Markets Global Healthcare Conference in New York on Tuesday, February 25, 2014. No formal presentation is scheduled, and the one-on-one...

2014-02-14 08:25:42

Leading Nongovernmental Funder of Epilepsy Research Awards $450,000 in Grants in Early 2014 CHICAGO, Feb. 14, 2014 /PRNewswire-USNewswire/ -- After receiving a record-high 200 plus applications in 2013, Citizens United for Research in Epilepsy (CURE) is proud to announce its six research grant recipients for the Taking Flight and Innovator awards. The surge in applications is credited to CURE's ongoing efforts to drive the epilepsy research agenda, funding innovative science not...

2014-02-11 08:30:26

LOS ANGELES, Feb. 11, 2014 /PRNewswire/ -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch(TM) eTNS(TM) System for the treatment of neurological and neuropsychiatric disorders, announced the appointment of Carl Adams as Vice President and Controller. Mr. Adams brings 20 years of experience in accounting and corporate finance to NeuroSigma. After nine years at Ernst and Young LLP, culminating as a...

2014-02-10 08:26:23

CHICAGO, Feb. 10, 2014 /PRNewswire-USNewswire/ -- The National Headache Foundation is pleased to announce that Melodie Winawer, M.D., M.S., is the recipient of the 2014 Seymour Diamond, M.D. Lectureship. Doctor Winawer is an Associate Professor of Neurology at Columbia University. Currently, she is involved in clinical, education, and research activities at the Columbia University Medical Center and Harlem Hospital in New York City. In addition to her work in neurology, she received...

2014-02-04 08:35:14

LA JOLLA, Calif., Feb. 4, 2014 /PRNewswire/ -- CorTechs Labs is pleased to announce the renewed and expanded partnership and distribution agreement with Invivo Corporation (subsidiary of Philips Healthcare) for NeuroQuant(®), the leading software solution for volumetric brain atrophy in the US healthcare market. As the only FDA approved solution that automatically quantifies the volumes of brain structures, NeuroQuant(®) is a key part of Invivo's DynaSuite Neuro Imaging Solution....

2014-01-31 23:33:53

“Psychogenic Non-Epileptic Seizures: A Guide” by Lorna Myers, Ph.D. provides readers with clear explanations about this serious psychological condition as well as tools to get back to a healthy life. New York, NY (PRWEB) January 31, 2014 Psychogenic Non-epileptic Seizures (PNES) can have devastating effects on those who develop it . PNES is a serious psychological condition that is still not well understood by doctors or the public. These seizures look very much like epileptic...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.